Doxycycline in Type II Diabetes
Conditions: Diabetes Mellitus, Type 2 Interventions: Drug: Sitagliptin 100mg; Drug: Doxycyclin Sponsors: Mostafa Bahaa Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 26, 2024 Category: Research Source Type: clinical trials
Anti-Diabetic Medications to Fight PD and LBD
Conditions: Lewy Body Dementia; Parkinson Disease Interventions: Drug: Sitagliptin; Drug: Dapagliflozin; Drug: Placebo Sponsors: Mayo Clinic Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 16, 2024 Category: Research Source Type: clinical trials
Comparative Effectiveness of Two Initial Combination Therapies in Patients With Recent Onset Diabetes
Conditions: Type 2 Diabetes (Adult Onset) Interventions: Drug: Tirzepatide; Drug: Pioglitazone; Drug: Sitagliptin; Drug: Metformin HCI XR Sponsors: The University of Texas Health Science Center at San Antonio; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 7, 2024 Category: Research Source Type: clinical trials
Sitagliptin and Metformin Hydrochloride Tablets 50 mg/500 mg Relative to Originator
Conditions: Healthy Subjects Interventions: Drug: Sitagliptin and Metformin Hydrochloride Tablets 50 mg/500 mg Test product; Drug: Sitagliptin and Metformin Hydrochloride Tablets 50 mg/500 mg Reference product Sponsors: Bio-innova Co., Ltd Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 31, 2024 Category: Research Source Type: clinical trials
Sitagliptin and Metformin Hydrochloride Tablets 50 mg/1000 mg Relative to Originator
Conditions: Healthy Subjects Interventions: Drug: Sitagliptin and Metformin Hydrochloride Tablets Test product; Drug: Sitagliptin and Metformin Hydrochloride Tablets Reference product Sponsors: Bio-innova Co., Ltd Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 31, 2024 Category: Research Source Type: clinical trials
A Clinical Trial to Evaluate the Food Effect on Pharmacokinetic Profiles and Safety of CKD-379
Conditions: Type 2 Diabetes Mellitus Interventions: Drug: CKD-379(Empagliflozin+sitagliptin+metformin) Test drug; Drug: CKD-379(Empagliflozin+sitagliptin+metformin) Reference drug Sponsors: Chong Kun Dang Pharmaceutical Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 12, 2024 Category: Research Source Type: clinical trials
Efficay and Safety of Empagliflozin Versus Sitagliptin for the In-patient Management of Hyperglycemia
Conditions: Type 2 Diabetes Interventions: Drug: Empagliflozin 25 MG; Drug: Sitagliptin 100mg Sponsors: Medanta, The Medicity, India; Diabetes& Endocrinology Foundation Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 1, 2024 Category: Research Source Type: clinical trials
To Compare the Safety and Efficacy of Dapagliflozin Plus Metformin Versus Sitagliptin Plus Metformin for Treatment of Diabetes in Patients With Compensated and Stable Decompensated Cirrhosis
Conditions: Compensated Cirrhosis; Decompensated Cirrhosis Interventions: Drug: Metformin; Drug: Sitagliptin; Drug: Dapagliflozin Sponsors: Institute of Liver and Biliary Sciences, India Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 27, 2023 Category: Research Source Type: clinical trials
Bioequivalence Study of Sitagliptin Hydrochloride / Metformin Hydrochloride Extended-release Film Coated Tablets 50 mg /500 mg (FDC) in Healthy Adult Male and Female Subjects Under Fed Conditions.
Conditions: Bioequivalence; Diabetes Mellitus, Type 2 Interventions: Drug: Sitagliptin/Metformin HCl 50/500 mg extended release film-coated tablet Sponsors: Galenicum Health Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 9, 2023 Category: Research Source Type: clinical trials
Bioequivalence Study of Sitagliptin Hydrochloride / Metformin Hydrochloride Extended-release Film Coated Tablets 100 mg /1000 mg (FDC) in Healthy Adult Male and Female Subjects Under Fed Conditions.
Conditions: Bioequivalence; Diabetes Mellitus, Type 2 Interventions: Drug: Sitagliptin/Metformin HCl 100/1000 mg extended release film-coated tablet Sponsors: Galenicum Health Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 9, 2023 Category: Research Source Type: clinical trials
Bioequivalence Study of Sitagliptin Hydrochloride / Metformin Hydrochloride Extended-release Film Coated Tablets 100 mg /1000 mg (FDC) in Healthy Adult Male and Female Subjects Under Fasting Conditions.
Conditions: Bioequivalence; Diabetes Mellitus, Type 2 Interventions: Drug: Sitagliptin/Metformin HCl 100/1000 mg extended release film-coated tablet Sponsors: Galenicum Health Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 9, 2023 Category: Research Source Type: clinical trials
Bioequivalence Study of Sitagliptin Hydrochloride / Metformin Hydrochloride Extended-release Film Coated Tablets 50 mg /500 mg (FDC) in Healthy Adult Male and Female Subjects Under Fasting Conditions.
Conditions: Bioequivalence; Diabetes Mellitus, Type 2 Interventions: Drug: Sitagliptin/Metformin HCl 50/500 mg extended release film-coated tablet Sponsors: Galenicum Health Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 9, 2023 Category: Research Source Type: clinical trials
The Impact of Sitagliptin as an Add on Therapy With Closed Loop Control in Adolescents With Diabetic Nephropathy
Conditions: Type 1 Diabetic Nephropathy Interventions: Drug: oral sitagliptin supplementation Sponsors: Ain Shams University; Ahram Canadian University Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 3, 2023 Category: Research Source Type: clinical trials
Study to Evaluate the Efficacy and Safety of DA-1241 in Subjects With Presumed NASH
Condition: NON-ALCOHOLIC STEATOHEPATITIS Interventions: Drug: DA-1241; Drug: Sitagliptin; Drug: DA-1241 Placebo; Drug: Sitagliptin Placebo Sponsor: NeuroBo Pharmaceuticals Inc. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 26, 2023 Category: Research Source Type: clinical trials
